Valuation: Glanbia

Market Cap 649.44Cr 563.59Cr 527.73Cr 482.74Cr 911.35Cr 62TCr 923.25Cr 6.17TCr 2.42TCr 31TCr 2.44TCr 2.39TCr 1,02900Cr P/E 2026 *
20.8x
P/E 2027 * 18.9x
Enterprise Value 714.14Cr 619.73Cr 580.31Cr 530.84Cr 1TCr 68TCr 1.02TCr 6.79TCr 2.66TCr 34TCr 2.68TCr 2.62TCr 1,13100Cr EV / Sales 2026 *
1.75x
EV / Sales 2027 * 1.63x
Free-Float
85.62%
Yield 2026 *
1.71%
Yield 2027 * 1.96%
Manager TitleAgeSince
Chief Executive Officer 55 01/01/2024
Director of Finance/CFO 62 12/11/2013
Investor Relations Contact - 01/10/2024
Director TitleAgeSince
Director/Board Member 62 12/11/2013
Director/Board Member 70 01/11/2020
Director/Board Member 61 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 649.44Cr
-0.19%-4.95%-4.53%-7.03% 2.47TCr
-3.46%-2.59%+10.70%-34.13% 941.06Cr
+2.02%+23.11%+113.76%+77.87% 858.32Cr
0.00%+3.22%+93.47%+66.92% 649.44Cr
-0.47%-0.47%+28.96%+102.72% 597.69Cr
+0.69%+0.89%+13.59%-22.84% 580.89Cr
-0.86%-0.11%+19.04%+2.00% 572.12Cr
-1.95%-3.11%-43.04%-41.41% 501.92Cr
+0.68%-3.59%-3.75%-19.18% 470.03Cr
Average +6.17%+1.42%+25.36%+13.88% 848.6Cr
Weighted average by Cap. +4.75%+0.97%+22.26%+10.52%

Financials

2026 *2027 *
Net sales 407.39Cr 353.53Cr 331.04Cr 302.82Cr 571.68Cr 39TCr 579.15Cr 3.87TCr 1.52TCr 19TCr 1.53TCr 1.5TCr 65TCr 421.84Cr 366.08Cr 342.79Cr 313.56Cr 591.96Cr 40TCr 599.69Cr 4.01TCr 1.57TCr 20TCr 1.58TCr 1.55TCr 67TCr
Net income 31Cr 27Cr 25Cr 23Cr 44Cr 2.99TCr 45Cr 298.19Cr 117.02Cr 1.49TCr 117.77Cr 115.21Cr 4.97TCr 34Cr 30Cr 28Cr 26Cr 48Cr 3.27TCr 49Cr 326.42Cr 128.1Cr 1.63TCr 128.92Cr 126.12Cr 5.44TCr
Net Debt 65Cr 56Cr 53Cr 48Cr 91Cr 6.16TCr 92Cr 615.07Cr 241.38Cr 3.08TCr 242.92Cr 237.64Cr 10TCr 38Cr 33Cr 31Cr 28Cr 53Cr 3.58TCr 53Cr 357.07Cr 140.13Cr 1.79TCr 141.03Cr 137.96Cr 5.95TCr
Logo Glanbia
Glanbia plc specializes in the production and commercialization of dairy, nutritional and food products for the food and pharmaceutical industries. Net sales break down by product family as follows: - nutritional and functional ingredients (54.4%): dairy, vegetable and functional proteins, nutrients (vitamins, trace elements, minerals, etc.), nutritional supplements for children, bioactive ingredients, etc. for dairy and non-dairy products (drinks, cereal bars, snacks, sauces, animal feed, etc.). The group is also developing a cheese production activity; - performance nutrition products (45.6%; world n°1): notably sports nutrition products (Optimum Nutrition, BSN, Isopure, thinkThin, Nutramino, ABB, Body & Fit and Amazing Grass brands). Net sales are distributed geographically as follows: Ireland (1.6%), Europe (13.6%), the United States (67.4%), North America (2.9%), Asia/Pacific (10.9%), Latin America (1.8%) and other (1.8%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
27.33USD
Average target price
26.95USD
Spread / Average Target
-1.39%

Quarterly revenue - Rate of surprise